Table of Contents

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
  • 1.2.2 Local Deployment
  • 1.2.3 Cloud Deployment
• 1.3 Market by Application
  • 1.3.1 Global Computational Medicine and Drug Designing Software Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Drug Discovery And Development
  • 1.3.3 Computational Physiological Medicine
  • 1.3.4 Disease Modeling
  • 1.3.5 Medical Imaging
  • 1.3.6 Predictive Analysis Of Drug Targets
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Computational Medicine and Drug Designing Software Market Perspective (2017-2028)
• 2.2 Computational Medicine and Drug Designing Software Growth Trends by Region
  • 2.2.1 Computational Medicine and Drug Designing Software Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Computational Medicine and Drug Designing Software Historic Market Size by Region (2017-2022)
  • 2.2.3 Computational Medicine and Drug Designing Software Forecasted Market Size by Region (2023-2028)
• 2.3 Computational Medicine and Drug Designing Software Market Dynamics
  • 2.3.1 Computational Medicine and Drug Designing Software Industry Trends
  • 2.3.2 Computational Medicine and Drug Designing Software Market Drivers
  • 2.3.3 Computational Medicine and Drug Designing Software Market Challenges
  • 2.3.4 Computational Medicine and Drug Designing Software Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Computational Medicine and Drug Designing Software Players by Revenue
  • 3.1.1 Global Top Computational Medicine and Drug Designing Software Players by Revenue (2017-2022)
  • 3.1.2 Global Computational Medicine and Drug Designing Software Revenue Market Share by Players (2017-2022)
• 3.2 Global Computational Medicine and Drug Designing Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Computational Medicine and Drug Designing Software Revenue
• 3.4 Global Computational Medicine and Drug Designing Software Market Concentration Ratio
  • 3.4.1 Global Computational Medicine and Drug Designing Software Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Computational Medicine and Drug Designing Software Revenue in 2021
• 3.5 Computational Medicine and Drug Designing Software Key Players Head office and Area Served
• 3.6 Key Players Computational Medicine and Drug Designing Software Product Solution and Service
• 3.7 Date of Enter into Computational Medicine and Drug Designing Software Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Computational Medicine and Drug Designing Software Breakdown Data by Type

• 4.1 Global Computational Medicine and Drug Designing Software Historic Market Size by Type (2017-2022)
• 4.2 Global Computational Medicine and Drug Designing Software Forecasted Market Size by Type (2023-2028)

5 Computational Medicine and Drug Designing Software Breakdown Data by Application

• 5.1 Global Computational Medicine and Drug Designing Software Historic Market Size by Application (2017-2022)
• 5.2 Global Computational Medicine and Drug Designing Software Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Computational Medicine and Drug Designing Software Market Size (2017-2028)
• 6.2 North America Computational Medicine and Drug Designing Software Market Size by Type
  • 6.2.1 North America Computational Medicine and Drug Designing Software Market Size by Type (2017-2022)
  • 6.2.2 North America Computational Medicine and Drug Designing Software Market Size by Type (2023-2028)
  • 6.2.3 North America Computational Medicine and Drug Designing Software Market Share by Type (2017-2028)
• 6.3 North America Computational Medicine and Drug Designing Software Market Size by Application
  • 6.3.1 North America Computational Medicine and Drug Designing Software Market Size by Application (2017-2022)
  • 6.3.2 North America Computational Medicine and Drug Designing Software Market Size by Application (2023-2028)
  • 6.3.3 North America Computational Medicine and Drug Designing Software Market Share by Application (2017-2028)
• 6.4 North America Computational Medicine and Drug Designing Software Market Size by Country
  • 6.4.1 North America Computational Medicine and Drug Designing Software Market Size by Country (2017-2022)
  • 6.4.2 North America Computational Medicine and Drug Designing Software Market Size by Country (2023-2028)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Computational Medicine and Drug Designing Software Market Size (2017-2028)
• 7.2 Europe Computational Medicine and Drug Designing Software Market Size by Type
  • 7.2.1 Europe Computational Medicine and Drug Designing Software Market Size by Type (2017-2022)
  • 7.2.2 Europe Computational Medicine and Drug Designing Software Market Size by Type (2023-2028)
  • 7.2.3 Europe Computational Medicine and Drug Designing Software Market Share by Type (2017-2028)
• 7.3 Europe Computational Medicine and Drug Designing Software Market Size by Application
  • 7.3.1 Europe Computational Medicine and Drug Designing Software Market Size by Application (2017-2022)
  • 7.3.2 Europe Computational Medicine and Drug Designing Software Market Size by Application (2023-2028)
  • 7.3.3 Europe Computational Medicine and Drug Designing Software Market Share by Application (2017-2028)
• 7.4 Europe Computational Medicine and Drug Designing Software Market Size by Country
  • 7.4.1 Europe Computational Medicine and Drug Designing Software Market Size by Country (2017-2022)
  • 7.4.2 Europe Computational Medicine and Drug Designing Software Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Computational Medicine and Drug Designing Software Market Size (2017-2028)
• 8.2 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Type
  • 8.2.1 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Type (2017-2022)
  • 8.2.2 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Type (2023-2028)
  • 8.2.3 Asia-Pacific Computational Medicine and Drug Designing Software Market Share by Type (2017-2028)
• 8.3 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Application
  • 8.3.1 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Computational Medicine and Drug Designing Software Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region
  • 8.4.1 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Computational Medicine and Drug Designing Software Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Computational Medicine and Drug Designing Software Market Size (2017-2028)
• 9.2 Latin America Computational Medicine and Drug Designing Software Market Size by Type
  • 9.2.1 Latin America Computational Medicine and Drug Designing Software Market Size by Type (2017-2022)
  • 9.2.2 Latin America Computational Medicine and Drug Designing Software Market Size by Type (2023-2028)
  • 9.2.3 Latin America Computational Medicine and Drug Designing Software Market Share by Type (2017-2028)
• 9.3 Latin America Computational Medicine and Drug Designing Software Market Size by Application
  • 9.3.1 Latin America Computational Medicine and Drug Designing Software Market Size by Application (2017-2022)
  • 9.3.2 Latin America Computational Medicine and Drug Designing Software Market Size by Application (2023-2028)
  • 9.3.3 Latin America Computational Medicine and Drug Designing Software Market Share by Application (2017-2028)
• 9.4 Latin America Computational Medicine and Drug Designing Software Market Size by Country
  • 9.4.1 Latin America Computational Medicine and Drug Designing Software Market Size by Country (2017-2022)
  • 9.4.2 Latin America Computational Medicine and Drug Designing Software Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Computational Medicine and Drug Designing Software Market Size (2017-2028)
• 10.2 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Type
  • 10.2.1 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Type (2017-2022)
  • 10.2.2 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Type (2023-2028)
  • 10.2.3 Middle East & Africa Computational Medicine and Drug Designing Software Market Share by Type (2017-2028)
• 10.3 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Application
  • 10.3.1 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Computational Medicine and Drug Designing Software Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country
  • 10.4.1 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Computational Medicine and Drug Designing Software Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Entelos
  • 11.1.1 Entelos Company Details
  • 11.1.2 Entelos Business Overview
  • 11.1.3 Entelos Computational Medicine and Drug Designing Software Introduction
  • 11.1.4 Entelos Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
  • 11.1.5 Entelos Recent Developments
• 11.2 Crown Bioscience
  • 11.2.1 Crown Bioscience Company Details
  • 11.2.2 Crown Bioscience Business Overview
  • 11.2.3 Crown Bioscience Computational Medicine and Drug Designing Software Introduction
  • 11.2.4 Crown Bioscience Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
  • 11.2.5 Crown Bioscience Recent Developments
• 11.3 Chemical Computing Group
  • 11.3.1 Chemical Computing Group Company Details
  • 11.3.2 Chemical Computing Group Business Overview
  • 11.3.3 Chemical Computing Group Computational Medicine and Drug Designing Software Introduction
  • 11.3.4 Chemical Computing Group Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
  • 11.3.5 Chemical Computing Group Recent Developments
• 11.4 Nimbus Therapeutics
  • 11.4.1 Nimbus Therapeutics Company Details
  • 11.4.2 Nimbus Therapeutics Business Overview
  • 11.4.3 Nimbus Therapeutics Computational Medicine and Drug Designing Software Introduction
  • 11.4.4 Nimbus Therapeutics Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
  • 11.4.5 Nimbus Therapeutics Recent Developments
• 11.5 Schrodinger
  • 11.5.1 Schrodinger Company Details
  • 11.5.2 Schrodinger Business Overview
  • 11.5.3 Schrodinger Computational Medicine and Drug Designing Software Introduction
  • 11.5.4 Schrodinger Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
  • 11.5.5 Schrodinger Recent Developments
• 11.6 Dassault Systemes
  • 11.6.1 Dassault Systemes Company Details
  • 11.6.2 Dassault Systemes Business Overview
  • 11.6.3 Dassault Systemes Computational Medicine and Drug Designing Software Introduction
  • 11.6.4 Dassault Systemes Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
  • 11.6.5 Dassault Systemes Recent Developments
• 11.7 Genedata
  • 11.7.1 Genedata Company Details
  • 11.7.2 Genedata Business Overview
  • 11.7.3 Genedata Computational Medicine and Drug Designing Software Introduction
  • 11.7.4 Genedata Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
  • 11.7.5 Genedata Recent Developments
• 11.8 Biognos
  • 11.8.1 Biognos Company Details
  • 11.8.2 Biognos Business Overview
  • 11.8.3 Biognos Computational Medicine and Drug Designing Software Introduction
  • 11.8.4 Biognos Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
  • 11.8.5 Biognos Recent Developments
• 11.9 Leadscope
  • 11.9.1 Leadscope Company Details
  • 11.9.2 Leadscope Business Overview
  • 11.9.3 Leadscope Computational Medicine and Drug Designing Software Introduction
  • 11.9.4 Leadscope Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
  • 11.9.5 Leadscope Recent Developments
• 11.10 Rhenovia Pharma Limited
  • 11.10.1 Rhenovia Pharma Limited Company Details
  • 11.10.2 Rhenovia Pharma Limited Business Overview
  • 11.10.3 Rhenovia Pharma Limited Computational Medicine and Drug Designing Software Introduction
  • 11.10.4 Rhenovia Pharma Limited Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
  • 11.10.5 Rhenovia Pharma Limited Recent Developments
• 11.11 Compugen
  • 11.11.1 Compugen Company Details
  • 11.11.2 Compugen Business Overview
  • 11.11.3 Compugen Computational Medicine and Drug Designing Software Introduction
  • 11.11.4 Compugen Revenue in Computational Medicine and Drug Designing Software Business (2017-2022)
  • 11.11.5 Compugen Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details

Summary:
Market Analysis and Insights: Global Computational Medicine and Drug Designing Software Market
The global Computational Medicine and Drug Designing Software market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Local Deployment accounting for % of the Computational Medicine and Drug Designing Software global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Drug Discovery And Development segment is altered to an % CAGR throughout this forecast period.
China Computational Medicine and Drug Designing Software market size is valued at US$ million in 2021, while the North America and Europe Computational Medicine and Drug Designing Software are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Computational Medicine and Drug Designing Software landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Computational Medicine and Drug Designing Software market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Computational Medicine and Drug Designing Software market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Computational Medicine and Drug Designing Software market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Computational Medicine and Drug Designing Software market.
Impact of Covid-19 Outbreak
This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
Segmental Analysis
The report has been segmented into product and application segments. The researchers have documented all the products present today in the Computational Medicine and Drug Designing Software market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
Computational Medicine and Drug Designing Software Breakdown Data by Type
Local Deployment
Cloud Deployment
Computational Medicine and Drug Designing Software Breakdown Data by Application
Drug Discovery And Development
Computational Physiological Medicine
Disease Modeling
Medical Imaging
Predictive Analysis Of Drug Targets
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
Entelos
Crown Bioscience
Chemical Computing Group
Nimbus Therapeutics
Schrodinger
Dassault Systemes
Genedata
Biognos
Leadscope
Rhenovia Pharma Limited
Compugen
Frequently Asked Questions
What factors will challenge the Computational Medicine and Drug Designing Software market growth?
Which end-use segment will expand at the fastest CAGR in the Computational Medicine and Drug Designing Software market?
Which are the emerging players in the Computational Medicine and Drug Designing Software market?
How concentrated is the Computational Medicine and Drug Designing Software market?
Which factors are positively contributing to the Computational Medicine and Drug Designing Software market growth?
Which are the novel product innovations in the Computational Medicine and Drug Designing Software market?
Which product segment will emerge as the most lucrative in the Computational Medicine and Drug Designing Software market?
Which factors are increasing the competition in the Computational Medicine and Drug Designing Software market?
Which are the strategic measures taken by the Computational Medicine and Drug Designing Software industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Computational Medicine and Drug Designing Software market in the coming years?